111 related articles for article (PubMed ID: 9399968)
1. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine.
Reid K; Guo TZ; Davies MF; Maze M
J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat.
Correa-Sales C; Nacif-Coelho C; Reid K; Maze M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568
[TBL] [Abstract][Full Text] [Related]
4. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats.
Horvàth G; Szikszay M; Benedek G
Anesth Analg; 1992 Jun; 74(6):884-8. PubMed ID: 1375817
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
6. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine.
Horváth G; Kovács M; Szikszay M; Benedek G
Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240
[TBL] [Abstract][Full Text] [Related]
7. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
Hayashi Y; Guo TZ; Maze M
Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
[TBL] [Abstract][Full Text] [Related]
8. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
Hayashi Y; Guo TZ; Maze M
Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat.
Rabin BC; Guo TZ; Maze M
Pharmacol Biochem Behav; 1997; 57(1-2):23-9. PubMed ID: 9164550
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
Melena J; Osborne NN
Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
Bol CJJG ; Danhof M; Stanski DR; Mandema JW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
[TBL] [Abstract][Full Text] [Related]
13. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
Schwinn DA; Correa-Sales C; Page SO; Maze M
J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct.
Rouch AJ; Kudo LH; Hébert C
J Pharmacol Exp Ther; 1997 Apr; 281(1):62-9. PubMed ID: 9103481
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with dexmedetomidine desensitizes alpha 2-adrenergic signal transduction.
Reid K; Hayashi Y; Hsu J; Maguire PA; Rabin BC; Guo TZ; Maze M
Pharmacol Biochem Behav; 1997; 57(1-2):63-71. PubMed ID: 9164555
[TBL] [Abstract][Full Text] [Related]
18. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks.
Ruotsalainen S; Haapalinna A; Riekkinen PJ; Sirviö J
Pharmacol Biochem Behav; 1997 Jan; 56(1):31-40. PubMed ID: 8981606
[TBL] [Abstract][Full Text] [Related]
20. Influence of T-type Ca2+ (mibefradil) and Cl- (indanyloxyacetic acid 94) channel antagonists on alpha1-adrenoceptor mediated contractions in rat aorta.
Duggan JA; Tabrizchi R
Can J Physiol Pharmacol; 2000 Sep; 78(9):714-20. PubMed ID: 11007534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
